Showing results (231-240 of 270) with videos related to
Sort By:
Pageof 27
JAMA|July 5, 1995
Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study GroupD W Bates, D J Cullen, N Laird, et al.Journal of the American Medical Informatics Association : JAMIA|June 3, 1998
Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary reportA K Jha, G J Kuperman, J M Teich, et al.Health Care Financing Review|August 3, 2001
Principal inpatient diagnostic cost group model for Medicare risk adjustmentG C Pope, R P Ellis, A S Ash, et al.Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001
A phylogenetic approach to following West Nile virus in ConnecticutJ F Anderson, C R Vossbrinck, T G Andreadis, et al.Journal of Wildlife Diseases|April 1, 1986
Spirochetes in ticks and antibodies to Borrelia burgdorferi in white-tailed deer from Connecticut, New York State, and North CarolinaL A Magnarelli, J F Anderson, C S Apperson, et al.Journal of Clinical Microbiology|September 17, 1998
Human exposure to a granulocytic Ehrlichia and other tick-borne agents in ConnecticutL A Magnarelli, J W Ijdo, J F Anderson, et al.Journal of the American Veterinary Medical Association|November 19, 1997
Antibodies to Ehrlichia equi in dogs from the northeastern United StatesL A Magnarelli, J W Ijdo, J F Anderson, et al.The American Journal of Tropical Medicine and Hygiene|April 13, 2000
SALP16, a gene induced in Ixodes scapularis salivary glands during tick feedingS Das, N Marcantonio, K Deponte, et al.Annals of the New York Academy of Sciences|January 19, 2002
West Nile virus envelope protein: role in diagnosis and immunityT Wang, J F Anderson, L A Magnarelli, et al.JAMA|December 12, 2001
Guided medication dosing for inpatients with renal insufficiencyG M Chertow, J Lee, G J Kuperman, et al.Pageof 27